These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11937534)

  • 1. Continuous exposure of mice to superantigenic toxins induces a high-level protracted expansion and an immunological memory in the toxin-reactive CD4+ T cells.
    Chen L; Koyanagi M; Fukada K; Imanishi K; Yagi J; Kato H; Miyoshi-Akiyama T; Zhang R; Miwa K; Uchiyama T
    J Immunol; 2002 Apr; 168(8):3817-24. PubMed ID: 11937534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term exposure to superantigen induces p27Kip1 and Bcl-2 expression in effector memory CD4+ T cells.
    Koyanagi M; Fukada K; Uchiyama T; Yagi J; Arimura Y
    Cell Immunol; 2007 Aug; 248(2):77-85. PubMed ID: 18001700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells.
    Goubard A; Loïez C; Abe J; Fichel C; Herwegh S; Faveeuw C; Porte R; Cayet D; Sebbane F; Penet S; Foligné B; Desreumaux P; Saito H; Sirard JC; Simonet M; Carnoy C
    Infect Immun; 2015 May; 83(5):2053-64. PubMed ID: 25754199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity of interaction between superantigen and T cell receptor Vbeta molecules induces a high level and prolonged expansion of superantigen-reactive CD4+ T cells.
    Omoe K; Nunomura W; Kato H; Li ZJ; Igarashi O; Araake M; Sano K; Ono HK; Abe Y; Hu DL; Nakane A; Kiyono H; Takakuwa Y; Shinagawa K; Uchiyama T; Imanishi K
    J Biol Chem; 2010 Oct; 285(40):30427-35. PubMed ID: 20663890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen.
    Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T
    J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
    Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
    J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 is required for induction and maintenance of immunological memory in toxin-reactive CD4+ T cells in vivo.
    Fukada K; Koyanagi M; Arimura Y; Ogiuchi H; Uchiyama T; Yagi J
    Cell Immunol; 2005 Dec; 238(2):103-12. PubMed ID: 16600196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further clonal expansion of T cells upon rechallenge of superantigen staphylococcal enterotoxin A.
    Aoki Y; Yoshikai Y
    Microbiol Immunol; 1997; 41(4):337-43. PubMed ID: 9159408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma.
    Cauley LS; Miller EE; Yen M; Swain SL
    J Immunol; 2000 Dec; 165(11):6056-66. PubMed ID: 11086037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms.
    Uchiyama T; Miyoshi-Akiyama T; Kato H; Fujimaki W; Imanishi K; Yan XJ
    J Immunol; 1993 Oct; 151(8):4407-13. PubMed ID: 8409410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superantigens anergize cytokine production but not cytotoxicity in vivo.
    Sundstedt A; Dohlsten M; Hedlund G; Höidén I; Björklund M; Kalland T
    Immunology; 1994 May; 82(1):117-25. PubMed ID: 7913912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo.
    Rosendahl A; Hansson J; Antonsson P; Sékaly RP; Kalland T; Dohlsten M
    Infect Immun; 1997 Dec; 65(12):5118-24. PubMed ID: 9393804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes.
    Davison S; Allen M; Vaughan R; Barker J
    Clin Exp Immunol; 2000 Aug; 121(2):181-6. PubMed ID: 10931129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM.
    Miyoshi-Akiyama T; Abe A; Kato H; Kawahara K; Narimatsu H; Uchiyama T
    J Immunol; 1995 May; 154(10):5228-34. PubMed ID: 7730627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of murine T cells reactive with the bacterial superantigen Yersinia pseudotuberculosis-derived mitogen (YPM) and factors involved in YPM-induced toxicity in mice.
    Miyoshi-Akiyama T; Fujimaki W; Yan XJ; Yagi J; Imanishi K; Kato H; Tomonari K; Uchiyama T
    Microbiol Immunol; 1997; 41(4):345-52. PubMed ID: 9159409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the functional region on the superantigen Yersinia pseudotuberculosis-derived mitogen responsible for induction of lymphocyte proliferation by using synthetic peptides.
    Yoshino K; Takao T; Ishibashi M; Samejima Y; Shimonishi Y; Takeda T
    FEBS Lett; 1996 Jul; 390(2):196-8. PubMed ID: 8706858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal expansion but lack of subsequent clonal deletion of bacterial superantigen-reactive T cells in murine retroviral infection.
    Aoki Y; Hiromatsu K; Usami J; Makino M; Igarashi H; Ogasawara J; Nagata S; Yoshikai Y
    J Immunol; 1994 Oct; 153(8):3611-21. PubMed ID: 7523498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superantigen enhancement of specific immunity: antibody production and signaling pathways.
    Torres BA; Perrin GQ; Mujtaba MG; Subramaniam PS; Anderson AK; Johnson HM
    J Immunol; 2002 Sep; 169(6):2907-14. PubMed ID: 12218104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferable anergy: superantigen treatment induces CD4+ T cell tolerance that is reversible and requires CD4-CD8- cells and interferon gamma.
    Cauley LS; Cauley KA; Shub F; Huston G; Swain SL
    J Exp Med; 1997 Jul; 186(1):71-81. PubMed ID: 9206999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of T cells in vivo induced by repeated superantigen treatments at different time intervals.
    Huang Y; Sui Y; Zhang X; Si S; Ge W; Hu P; Li X; Ma B
    Acta Biochim Biophys Sin (Shanghai); 2007 Jul; 39(7):467-74. PubMed ID: 17622466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.